Fiera Capital Corp Abbott Laboratories Transaction History

Fiera Capital Corp

$30.3 Billion
Q4 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $594,803 - $656,933	-5,431 Reduced 72.4%	2,070 $235,000
Q4 2023 Aug 22, 2024	SELL	$90.19 - $110.4 $307,638 - $376,574	-3,411 Reduced 31.26%	7,501 $825,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $307,638 - $376,574	-3,411 Reduced 31.26%	7,501 $825,000
Q3 2023 Aug 22, 2024	BUY	$95.53 - $114.62 $844,676 - $1.01 Million	8,842 Added 427.15%	10,912 $1.06 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $35,632 - $42,753	373 Added 3.54%	10,912 $1.06 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $336,907 - $375,385	-3,343 Reduced 24.08%	10,539 $1.15 Million
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $59,181 - $69,660	611 Added 4.6%	13,882 $1.41 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $107,988 - $126,686	-1,136 Reduced 7.89%	13,271 $1.46 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $408,714 - $473,214	4,224 Added 41.48%	14,407 $1.39 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $101,661 - $122,876	996 Added 10.84%	10,183 $1.11 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $629,960 - $768,196	-5,525 Reduced 37.55%	9,187 $1.09 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $519,885 - $636,570	4,500 Added 44.07%	14,712 $2.07 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $97,994 - $108,410	840 Added 8.96%	10,212 $1.21 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $96,268 - $113,322	910 Added 10.75%	9,372 $857,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $385,620 - $454,318	-3,543 Reduced 29.51%	8,462 $1.01 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $31,920 - $34,783	304 Added 2.6%	12,005 $1.31 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $1.52 Million - $1.85 Million	-16,630 Reduced 58.7%	11,701 $1.27 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $544,106 - $696,388	7,106 Added 33.48%	28,331 $2.59 Million
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $97,371 - $142,383	-1,550 Reduced 6.81%	21,225 $1.68 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $86,989 - $96,839	-1,108 Reduced 4.64%	22,775 $1.98 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $336,198 - $364,543	-4,108 Reduced 14.68%	23,883 $2 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $57,210 - $66,725	785 Added 2.89%	27,991 $2.35 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $42,049 - $50,838	-635 Reduced 2.28%	27,206 $2.18 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $72,968 - $82,662	-1,113 Reduced 3.84%	27,841 $2.01 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $262,212 - $316,328	-4,312 Reduced 12.96%	28,954 $2.13 Million
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $726,130 - $801,430	12,613 Added 61.07%	33,266 $2.03 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $67,130 - $75,898	-1,193 Reduced 5.46%	20,653 $1.24 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $21,901 - $23,447	408 Added 1.9%	21,846 $1.25 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.03 Million - $1.15 Million	21,438	21,438 $1.14 Million

Others Institutions Holding ABT

# of Institutions

3,378

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$21.4 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$16.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$9.78 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$8.62 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$6.86 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account